Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
Iron
Pharmacosmos A/S
B03AC
Iron
100 milligram(s)/millilitre
Solution for injection/infusion
Product subject to prescription which may not be renewed (A)
Iron, parenteral preparations
Not marketed
2010-04-09
2 PACKAGE LEAFLET: INFORMATION FOR THE USER MONOVER ® 100 MG/ML SOLUTION FOR INJECTION/INFUSION _ _ ferric derisomaltose READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Monover is and what it is used for 2. What you need to know before you receive Monover 3. How Monover is administered 4. Possible side effects 5. How to store Monover 6. Contents of the pack and other information. 1. WHAT MONOVER IS AND WHAT IT IS USED FOR Monover contains a combination of iron and derisomaltoside (a chain of sugar molecules). The type of iron in Monover is the same as that found naturally in the body called ‘ferritin’. This means that you can have Monover by injection in high doses. Monover is used for low levels of iron (sometimes called ‘iron deficiency’ and ‘iron deficiency anaemia’) if: • Oral iron does not work or you cannot tolerate it • Your doctor decides you need iron very quickly to build up your iron stores 2. WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE MONOVER YOU MUST NOT RECEIVE MONOVER: • if you are allergic (hypersensitive) to the product or any of the other ingredients of this medicine (listed in section 6). • if you have experienced serious allergic (hypersensitive) reactions to other injectable iron preparations. • if you have anaemia NOT caused by iron deficiency • if you have too much iron (overload) or a problem in the way your body uses iron • if you have liver problems such as ‘cirrhosis’ WARNINGS AND PRECAUTIONS Talk to your doctor or nurse before receiving Monover: • if you have a history of medicine allergy • if you have systemic lupus erythematosus • if you have rheumatoid arthritis • if you have severe asth Pročitajte cijeli dokument
Health Products Regulatory Authority 07 March 2023 CRN00DG98 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Monover 100 mg/ml solution for injection/infusion (ampoules) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One millilitre of solution contains 100 mg iron as ferric derisomaltose 1 ml ampoule contains 100 mg iron as ferric derisomaltose 2 ml ampoule contains 200 mg iron as ferric derisomaltose 5 ml ampoule contains 500 mg iron as ferric derisomaltose 10 ml ampoule contains 1,000 mg iron as ferric derisomaltose For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection/infusion. Dark brown, non transparent solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Monover is indicated for the treatment of iron deficiency in the following conditions: - When oral iron preparations are ineffective or cannot be used - Where there is a clinical need to deliver iron rapidly The diagnosis must be based on laboratory tests. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Monitor carefully patients for signs and symptoms of hypersensitivity reactions during and following each administration of Monover. Monover should only be administered when staff trained to evaluate and manage anaphylactic reactions is immediately available, in an environment where full resuscitation facilities can be assured. The patient should be observed for adverse effects for at least 30 minutes following each Monover injection (see section 4.4). Each IV iron administration is associated with a risk of a hypersensitivity reaction. Thus, to minimise risk the number of single IV iron administrations should be kept to a minimum. POSOLOGY The posology of Monover follows a stepwise approach: [1] determination of the individual iron need and [2] calculation and administration of the iron dose(s). The steps can be repeated after [3] post-iron repletion assessments. _Step 1: Determination of the iron need:_ The iron need can be determined using either the Simplified Table (i) or the Ganzoni Pročitajte cijeli dokument